Literature DB >> 17554567

Laboratory diagnosis of Mycoplasma pneumoniae respiratory tract infections in children.

E Souliou1, M Almasri, A Papa, A Theodoridou, E Diza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554567     DOI: 10.1007/s10096-007-0326-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


× No keyword cloud information.
  9 in total

1.  An interlaboratory comparison for the detection of Mycoplasma pneumoniae in respiratory samples by the polymerase chain reaction.

Authors:  D Ursi; M Ieven; G T Noordhoek; M Ritzler; H Zandleven; M Altwegg
Journal:  J Microbiol Methods       Date:  2003-06       Impact factor: 2.363

2.  Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection.

Authors:  R Nir-Paz; A Michael-Gayego; M Ron; C Block
Journal:  Clin Microbiol Infect       Date:  2006-07       Impact factor: 8.067

3.  Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals.

Authors:  J Gnarpe; A Lundbäck; B Sundelöf; H Gnarpe
Journal:  Scand J Infect Dis       Date:  1992

4.  Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction-based test for Mycoplasma pneumoniae.

Authors:  M Reznikov; T K Blackmore; J J Finlay-Jones; D L Gordon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

Review 5.  Laboratory diagnosis of Mycoplasma pneumoniae infection.

Authors:  F Daxboeck; R Krause; C Wenisch
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

6.  Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR.

Authors:  D Nadal; W Bossart; F Zucol; F Steiner; C Berger; U Lips; M Altwegg
Journal:  Diagn Microbiol Infect Dis       Date:  2001-01       Impact factor: 2.803

7.  Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients.

Authors:  M Ieven; D Ursi; H Van Bever; W Quint; H G Niesters; H Goossens
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

8.  Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction.

Authors:  L Skakni; A Sardet; J Just; J Landman-Parker; J Costil; N Moniot-Ville; F Bricout; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Diagnosis of Mycoplasma pneumoniae pneumonia in children.

Authors:  M E Waris; P Toikka; T Saarinen; S Nikkari; O Meurman; R Vainionpää; J Mertsola; O Ruuskanen
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  9 in total
  5 in total

1.  Mycoplasma pneumoniae respiratory tract infections among Greek children.

Authors:  M Almasri; E Diza; A Papa; M Eboriadou; E Souliou
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

2.  Epidemiology of community-acquired Mycoplasma Pneumoniae respiratory tract infections among hospitalized Chinese children, including relationships with meteorological factors.

Authors:  Z R Chen; Y D Yan; Y Q Wang; H Zhu; X J Shao; J Xu; W Ji
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

3.  Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin.

Authors:  E Pavlou; A Gkampeta; K Kouskouras; A Evangeliou; F Athanasiadou-Piperopoulou
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

Review 4.  PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis.

Authors:  Lei Zhang; Zhi-Yong Zong; Yan-Bin Liu; Hui Ye; Xiao-Ju Lv
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

5.  Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia.

Authors:  Hai Lee Chung; Jin Young Shin; Mi Ju; Woo Taek Kim; Sang Gyung Kim
Journal:  Cytokine       Date:  2011-02-26       Impact factor: 3.861

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.